Bentham Science Logo

Track Your Manuscript:


Endocrine, Metabolic & Immune Disorders - Drug Targets

Formerly: Current Drug Targets - Immune, Endocrine & Metabolic Disorders

Volume 21, 12 Issues, 2021
ISSN: 2212-3873 (Online)
ISSN: 1871-5303 (Print)
This journal supports open access

Contents

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Volume 4 - Number 1

Melatonin Role in Experimental Arthritis

, 4(1): 1 - 10

Daniel P. Cardinali, Ana P. Garcia, Pilar Cano and Ana I. Esquifino


DOI: 10.2174/1568008043340071







HDL and Inflammation in Atherosclerosis

, 4(1): 51 - 57

Lukas E. Spieker, Frank Ruschitzka, Thomas F. Luscher and Georg Noll


DOI: 10.2174/1568005310404010051



The Paracrine Role Played by Interleukin-1α in the Testis

, 4(1): 67 - 74

K. Svechnikov, C. Petersen, T. Sultana, A. Wahlgren, C. Zetterstrom, E. Colon, C. Bornestaf and O. Soder


DOI: 10.2174/1568005310404010067






Editor-in-Chief

Emilio Jirillo
Department of Basic Medical Sciences Neuroscience and Sensory Organs
University of Bari “Aldo Moro”
Bari
(Italy)
Biography
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Drug Targets - Immune, Endocrine & Metabolic Disorders was launched in 2001 and later renamed in 2006 as Endocrine, Metabolic & Immune Disorders - Drug Targets.

Related Journals

Related eBooks

eBooks Catalog